The Role of Circulating Tumour DNA in Head and Neck Cancer

Abroad (travel likely)Recruiting

Conditions

Oropharyngeal Squamous Cell Carcinoma · Human Papillomavirus (HPV)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Ninewells Hospital, Dundee, DD2 1SG, United Kingdom
Contact: Study coordinator (Jai Manickavasagam) · jai.manickavasagam@nhs.scot
Summerfield House - NHS Grampian, Aberdeen, United Kingdom
Contact: Study coordinator (Kim Ah-see) · kim.ah-see2@nhs.scot
Monklands Hospital ENT, Airdrie, United Kingdom
Contact: Study coordinator (Robin Crosbie) · Robin.Crosbie@lanarkshire.scot.nhs.uk
The Royal Infirmiry, Edinburgh, United Kingdom
Contact: Study coordinator (Ashley Hay) · tim.aitman@ed.ac.uk
Glasgow Royal Infirmary, Glasgow, United Kingdom
Contact: Study coordinator (Catriona Douglas) · Catriona.Douglas@ggc.scot.nhs.uk

Study leads

Ashley Tay
Principal Investigator
NHS Lothian
Catriona Douglas
Principal Investigator
NHS Greater Glasgow and Clyde
Robin Crosbie
Principal Investigator
NHS Lanarkshire
Jaiganesh Manickavasagam
Principal Investigator
NHS Tayside
Kim Ah-see
Principal Investigator
NHS Grampian

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer

Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Head and Neck Carcinoma of Unknown Primary

Abroad (travel likely)RecruitingPHASE1

Tampa, United States · Chicago, United States

Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients With Locally Advanced, HPV16-Positive Oropharyngeal Squamous-Cell Carcinoma

Oropharyngeal Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE2

St Louis, United States

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma · Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 · Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7

Abroad (travel likely)RecruitingPHASE2, PHASE3

Birmingham, United States · Birmingham, United States

E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers

HPV-Associated Cervical Carcinoma · HPV-Related Carcinoma · HPV-Related Malignancy

Abroad (travel likely)RecruitingPHASE1, PHASE2

New Brunswick, United States · New Brunswick, United States